UK finalizes veterinary reforms targeting pet care costs

The UK has moved from investigation to action in its long-running review of veterinary services for household pets, with the Competition and Markets Authority finalizing a major reform package on March 24, 2026. The headline changes are designed to address what regulators describe as weak price transparency, limited comparability between practices, and consumer confusion about corporate ownership, medicine pricing, and complaints pathways. In practical terms, veterinary businesses will face new obligations around publishing prices, disclosing ownership, documenting estimates and bills, and supporting pet parents who want to shop around for medicines. (gov.uk)

The reforms are the endpoint of a process that began with a CMA call for information in September 2023, escalated to a formal market investigation in May 2024, and continued through provisional findings and remedies consultations in 2025. The CMA’s earlier work had flagged multiple structural concerns, including limited upfront pricing, consolidation among large veterinary groups, and the difficulty pet parents face in making cost-sensitive decisions during stressful or urgent clinical moments. By October 2025, the regulator had already signaled that major changes were likely, and by June 2025 it had extended the timetable, citing the complexity of the sector and the need to avoid unintended consequences. (gov.uk)

The final package is notable for how operational it is. Practices will need to publish comprehensive price lists for standard services, including consultations, common procedures, diagnostics, written prescriptions, and cremation options. Price and ownership information will also feed into the Royal College of Veterinary Surgeons’ “Find a Vet” service for wider comparison use. For non-emergency treatment expected to cost £500 or more, practices must provide written estimates in advance, including aftercare, and then issue itemized bills. The CMA also concluded that many pet parents were paying too much for written prescriptions, so it imposed a cap of £21 for the first medicine and £12.50 for additional medicines from the same consultation. It further requires practices to tell pet parents they can request a written prescription, which the CMA says could save some households £200 a year or more on long-term medications bought online. (gov.uk)

Other parts of the package go beyond headline pricing. Practices must clearly state whether they’re part of a group or independent business, with common ownership shown in-practice and online. Pet care plans will need clearer breakdowns of component pricing and advertised savings. Cremation pricing must be more transparent, including lower-cost communal options. Practices will also need transparent in-house complaints processes, and out-of-hours providers will face limits on long notice periods and exit fees that can make it hard for clinics to switch vendors. The CMA framed these changes as a way to improve both consumer choice and trust, while also requiring practices to maintain written policies that support independent, impartial clinical advice. (gov.uk)

Reaction from inside the profession has been measured rather than celebratory. In a joint response during the remedies process, BVA, BSAVA, BVNA, SPVS, and VMG said they broadly agreed with the CMA that veterinary services are unusually hard for consumers to assess, because care is often purchased under stress, trust in clinical judgment is central, and advances in medicine have increased costs. At the same time, they warned that the cumulative burden of the remedies could be “very significant,” particularly for practices already operating under staffing, cost, and capacity pressure. BSAVA separately said it welcomed reform of the Veterinary Surgeons Act 1966, especially the case for regulating businesses rather than only individual veterinary surgeons and nurses, but urged adequate time for the sector to adapt. A corporate operator, The Pet Vet, publicly welcomed the final reforms and said it was already meeting many of the transparency expectations, suggesting larger groups may be better positioned than smaller independents to absorb compliance work. (bvna.org.uk)

Why it matters: For veterinary professionals, the UK story is really about the collision between consumer protection, corporate consolidation, and the limits of a regulatory framework built for a different era. The CMA explicitly said the current legal regime is roughly 60 years old and does not adequately regulate veterinary businesses or practices, which helps explain why the remedies package extends from pricing to governance and complaints. That matters operationally: compliance won’t sit only with finance or reception teams. It will affect clinician communication, consent processes, medicine workflows, website content, software systems, and how practices document independence of clinical advice. For US readers, the bigger signal is that veterinary pricing and ownership transparency are no longer niche policy issues. Inference: if UK implementation is seen as workable, similar scrutiny could spread to other consolidated companion animal markets, including parts of the US. (gov.uk)

What to watch: The implementation timeline is staggered, with some remedies starting in September 2026 and others extending through 2027 and into 2028, including RCVS-related elements. That gives practices time, but it also means a long transition period in which interpretation, enforcement, and practical workarounds will matter almost as much as the rules themselves. The key issues to monitor are whether smaller practices can comply without margin erosion, whether comparison tools actually help pet parents make decisions, and whether the longer-term push for Veterinary Surgeons Act reform turns these competition remedies into a broader reset of UK practice regulation. (assets.publishing.service.gov.uk)